Venous Thromboembolism (VTE) – Boston Collaborative Drug Surveillance Program (BCDSP)

Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20-59 Years in the United Kingdom’s CPRD 1995-2015

By BCDSP January 20, 2022Uncategorized, Venous Thromboembolism (VTE)

Journal: Clinical Epidemiology Authors: Olulade A Ayodele, Howard J Cabral, David D McManus, Susan S Jick NLM Citation: Ayodele OA, Cabral HJ, McManus DD, Jick SS. Glucocorticoids and Risk of Venous Thromboembolism in…

The risk of venous thromboembolism (VTE) in men with benign prostatic hyperplasia treated with 5-Alpha Reductase Inhibitors (5ARIs)

By BCDSP August 3, 20215-Alpha Reductase Inhibitor (5ARI), PhD Studies, Select Publications, Student Studies, Venous Thromboembolism (VTE)

Journal: Clinical Epidemiology Authors: Olulade Ayodele, Howard J Cabral, David McManus, Susan Jick NLM Citation: Ayodele O, Cabral HJ, McManus D, Jick S. The Risk of Venous Thromboembolism (VTE) in Men with Benign…

Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD

By BCDSP September 7, 2014Mental Health, Safety of other important drugs, Venous Thromboembolism (VTE)

Journal: Pharmacoepidemiology and Drug Safety Authors: Chieko Ishiguro 1, Xi Wang, Lin Li, Susan Jick NLM Citation: Ishiguro C, Wang X, Li L, Jick S. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a…